Disease-free survival rate of 58% at 12 months (primary endpoint) and 52% at 24 months Cystectomy avoidance rate of 82% at 36 months—unmatched by any product in the field to date Disease-specific ...
ZUSDURI shows promising long-term efficacy in treating low-grade intermediate-risk bladder cancer, maintaining event-free survival in patients. UroGen Pharma Ltd. announced findings published in the ...
(Reuters Health) - Several different types of mesh implant surgery may be effective for treating bladder leaks, but the long-term safety and effectiveness of the procedures isn't yet clear, a new ...
Dr Sarita Naik (Narang) is a superspecialist urogynaceologist & vaginal surgeon in Mumbai. She earned her MBBS with a gold medal in 2003 from Maulana Azad Medical College, Delhi University. She was ...
Segments of gastrointestinal tract are commonly used for bladder augmentation (BA) to treat patients with neurogenic bladder or bladder exstrophy (1,2). However, when gastrointestinal tissue is in ...
In consideration of visiting the loo “just in case,” the behavior seems to be sound advice, from before long car rides, ...
Oral presentation from QUILT-3.032 study showed 71% complete response rate (N=100), with duration of response ranging up to more than 53 months, in BCG-unresponsive NMIBC CIS with or without papillary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback